Skip to main content

Connective Tissue Diseases Workgroup

Workgroup Chairs

  • JOSEPH MEROLA

    MD, MMSc

  • ALICE GOTTLIEB

    MD, PhD

  • LOURDES PEREZ-CHADA

    MD, MMSc

  • VIBEKE STRAND

    MD, FACP, MACR

Connective Tissue Diseases Workgroup (encompasses CLE, DM, sclerosing disorders and other related conditions).

Initially focused on CLE:

  • Expand upon a recently proposed ‘working’ core domain and core outcome measure set (COS) for CLE clinical trials, taking a formal approach to a consensus-based set through IDEOM
  • Consider data needs to support the COS including SLR, application of OMERACT filter
  • Consider unmet needs in outcome measure development for CLE, including revisions to existing IGA and other instruments.

Publications

  1. Development of a working core outcome set for cutaneous lupus erythematosus: a practical approach to an urgent unmet need - PubMed. Read More